Quipt Home Medical Rejects Forager’s Acquisition Proposal

Quipt Home Medical ( (TSE:QIPT) ) just unveiled an announcement.

On August 27, 2025, Quipt Home Medical Corp. confirmed receipt of another unsolicited, non-binding proposal from Forager Capital Management, LLC to acquire all of the company’s shares at $3.10 per share, a reduction from a previous offer of $3.90 per share in January 2025. The board of Quipt Home Medical has rejected these offers, citing undervaluation and concerns over Forager’s failure to comply with U.S. securities laws. The board remains focused on enhancing long-term shareholder value and is open to engaging with Forager if they agree to a confidentiality agreement.

The most recent analyst rating on (TSE:QIPT) stock is a Hold with a C$3.50 price target. To see the full list of analyst forecasts on Quipt Home Medical stock, see the TSE:QIPT Stock Forecast page.

Spark’s Take on TSE:QIPT Stock

According to Spark, TipRanks’ AI Analyst, TSE:QIPT is a Neutral.

Quipt Home Medical’s overall score reflects strong revenue growth and cash flow management, balanced by challenges in profitability and valuation concerns. The company’s strategic expansions and stable EBITDA margins are positive, but year-over-year revenue declines and increased expenses pose risks.

To see Spark’s full report on TSE:QIPT stock, click here.

More about Quipt Home Medical

Quipt Home Medical Corp. is a U.S.-based provider of in-home monitoring and disease management services, focusing on end-to-end respiratory solutions. The company aims to expand its offerings to manage chronic diseases such as heart or pulmonary disease, sleep disorders, and reduced mobility, with a strategy to increase annual revenue per patient by offering multiple services.

Average Trading Volume: 36,017

Technical Sentiment Signal: Hold

Current Market Cap: C$158.1M

For an in-depth examination of QIPT stock, go to TipRanks’ Overview page.